Letter to the Editor on “Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid”

Guillermo A. Bonilla, Camilo Gutierrez, Maria P. Bautista, Adolfo M. Llinas, Daniel J. Monsalvo

Producción científica: Contribución a una revistaCartarevisión exhaustiva

Resumen

We had the opportunity to read last issue’s article by Sharfman et al [1] regarding the use of an intermittent pneumatic compression device (IPCD) and tranexamic acid (TXA) as prophylactic measures against venous thromboembolic disease and bleeding, respectively. The authors’ research on the subject is a valuable contribution to the study of relevant perioperative complications after hip or knee arthroplasty, and their stepwise approach demonstrated interesting results in patient outcomes [1]. Nevertheless, we would like to contribute some observations that could lead to a better understanding of this article, especially regarding its main conclusion.
Idioma originalInglés estadounidense
Páginas (desde-hasta)2653-2654
Número de páginas2
PublicaciónJournal of Arthroplasty
Volumen31
N.º11
DOI
EstadoPublicada - nov. 1 2016
Publicado de forma externa

Áreas temáticas de ASJC Scopus

  • Ortopedia y medicina del deporte

Huella

Profundice en los temas de investigación de 'Letter to the Editor on “Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid”'. En conjunto forman una huella única.

Citar esto